{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:30:47Z","timestamp":1769171447175,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["2024TJCR008"],"award-info":[{"award-number":["2024TJCR008"]}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["2024TJCR008"],"award-info":[{"award-number":["2024TJCR008"]}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["2024TJCR008"],"award-info":[{"award-number":["2024TJCR008"]}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["2024TJCR008"],"award-info":[{"award-number":["2024TJCR008"]}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["2024TJCR008"],"award-info":[{"award-number":["2024TJCR008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-024-03472-w","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:56:38Z","timestamp":1736492198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Eltrombopag for the treatment of refractory connective tissue disease-related thrombocytopenia: a pilot study of 52 cases"],"prefix":"10.1186","volume":"27","author":[{"given":"Siying","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaozhe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"issue":"10","key":"3472_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune Thrombocytopenia. N Engl J Med. 2019;381(10):945\u201355.","journal-title":"N Engl J Med"},{"issue":"6","key":"3472_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MOH.0000000000000612","volume":"27","author":"JW Semple","year":"2020","unstructured":"Semple JW, Rebetz J, Maouia A, Kapur R. An update on the pathophysiology of immune thrombocytopenia. Curr Opin Hematol. 2020;27(6):423\u20139.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"3472_CR3","doi-asserted-by":"publisher","first-page":"e000078","DOI":"10.1136\/lupus-2014-000078","volume":"2","author":"A Fayyaz","year":"2015","unstructured":"Fayyaz A, Igoe A, Kurien BT, Danda D, James JA, Stafford HA, et al. Haematological manifestations of lupus. Lupus Sci Med. 2015;2(1):e000078.","journal-title":"Lupus Sci Med"},{"issue":"5","key":"3472_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/1756-185X.13464","volume":"22","author":"M Tsukamoto","year":"2019","unstructured":"Tsukamoto M, Suzuki K, Takeuchi T. Ten-year observation of patients with primary Sj\u00f6gren\u2019s syndrome: initial presenting characteristics and the associated outcomes. Int J Rheum Dis. 2019;22(5):929\u201333.","journal-title":"Int J Rheum Dis"},{"key":"3472_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejim.2022.11.022","volume":"108","author":"A Gafter-Gvili","year":"2023","unstructured":"Gafter-Gvili A. Current approaches for the diagnosis and management of immune thrombocytopenia. Eur J Intern Med. 2023;108:18\u201324.","journal-title":"Eur J Intern Med"},{"issue":"8","key":"3472_CR6","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/j.1538-7836.2005.01376.x","volume":"3","author":"BH Chong","year":"2005","unstructured":"Chong BH, Ho SJ. Autoimmune thrombocytopenia. J Thromb Haemost. 2005;3(8):1763\u201372.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3472_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-023-01401-z","volume":"16","author":"X-G Liu","year":"2023","unstructured":"Liu X-G, Hou Y, Hou M. How we treat primary immune thrombocytopenia in adults. J Hematol Oncol. 2023;16(1):4.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3472_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/rheumatology\/kead160","volume":"63","author":"H Du","year":"2024","unstructured":"Du H, Su W, Su J, Hu J, Wu D, Long W, et al. Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study. Rheumatology (Oxford). 2024;63(1):79\u201384.","journal-title":"Rheumatology (Oxford)"},{"issue":"22","key":"3472_CR9","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780\u2013817.","journal-title":"Blood Adv"},{"issue":"9978","key":"3472_CR10","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(14)61495-1","volume":"385","author":"W Ghanima","year":"2015","unstructured":"Ghanima W, Khelif A, Waage A, Michel M, Tj\u00f8nnfjord GE, Romdhan NB, et al. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet (London England). 2015;385(9978):1653\u201361.","journal-title":"Lancet (London England)"},{"issue":"2","key":"3472_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/joim.13742","volume":"295","author":"OD Ogbue","year":"2024","unstructured":"Ogbue OD, Bahaj W, Kewan T, Ahmed R, Dima D, Willimas N, et al. Splenectomy outcomes in immune cytopenias: treatment outcomes and determinants of response. J Intern Med. 2024;295(2):229\u201341.","journal-title":"J Intern Med"},{"issue":"7","key":"3472_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1182\/blood.2019003599","volume":"135","author":"OHM Miltiadous","year":"2020","unstructured":"Miltiadous OHM, Bussel JB. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment. Blood. 2020;135(7):472\u201390.","journal-title":"Blood"},{"issue":"16","key":"3472_CR13","first-page":"1905","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham A, Avatrombopag. Rev Thrombocytopenia Drugs. 2021;81(16):1905\u201313.","journal-title":"Rev Thrombocytopenia Drugs"},{"issue":"5","key":"3472_CR14","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10067-022-06464-w","volume":"42","author":"W Li","year":"2023","unstructured":"Li W, Wang D, Ma L, Zhu Y, Wang F, Hua B, et al. Eltrombopag in severe immune thrombocytopenia secondary to connective tissue disease: a report of 17 patients and literature review. Clin Rheumatol. 2023;42(5):1451\u20137.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3472_CR15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3472_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2016","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s syndrome: a Consensus and Data-Driven Methodology Involving Three International Patient cohorts. Arthritis Rheumatol. 2016;69(1):35\u201345.","journal-title":"Arthritis Rheumatol"},{"key":"3472_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cyto.2018.05.009","volume":"110","author":"M Akiyama","year":"2018","unstructured":"Akiyama M, Yasuoka H, Yoshimoto K, Takeuchi T. Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease. Cytokine. 2018;110:416\u20139.","journal-title":"Cytokine"},{"issue":"5","key":"3472_CR18","first-page":"615","volume":"17","author":"M Mosca","year":"1999","unstructured":"Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999;17(5):615\u201320.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3472_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"3472_CR20","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 111","key":"3472_CR21","first-page":"85","volume":"36","author":"J Yoo","year":"2018","unstructured":"Yoo J, Kim HJ, Ahn SS, Jung SM, Song JJ, Park Y-B, et al. The utility of the ACR\/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Rheumatol. 2018;36(Suppl 111):85\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"3472_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","volume":"104","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104(6):1112\u201323.","journal-title":"Haematologica"},{"key":"3472_CR23","doi-asserted-by":"crossref","unstructured":"Cooper N, Scully M, Percy C, Nicolson PLR, Lowe G, Bagot CN et al. Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: results from the TRAIT study. Br J Haematol. 2024.","DOI":"10.1111\/bjh.19345"},{"issue":"11","key":"3472_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s40265-021-01553-7","volume":"81","author":"J Gilreath","year":"2021","unstructured":"Gilreath J, Lo M, Bubalo J. Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists. Drugs. 2021;81(11):1285\u2013305.","journal-title":"Drugs"},{"issue":"7","key":"3472_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/RHU.0000000000001083","volume":"26","author":"V Shobha","year":"2020","unstructured":"Shobha V, Sanil S, Roongta R, Eltrombopag. Efficacy and safety in Steroid Refractory Lupus-Associated Immune Thrombocytopenia. J Clin Rheumatol. 2020;26(7):274\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"3472_CR26","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1038\/s41598-021-84493-2","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Dai M, Fu Q, Chen S. Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease. Sci Rep. 2021;11(1):5459.","journal-title":"Sci Rep"},{"issue":"2","key":"3472_CR27","doi-asserted-by":"publisher","first-page":"368504221102786","DOI":"10.1177\/00368504221102786","volume":"105","author":"L Xu","year":"2022","unstructured":"Xu L, Zhang Y, Lin N, Song X, Dai Q. Eltrombopag improves refractory thrombocytopenia in patients with Sj\u00f6gren\u2019s syndrome. Sci Prog. 2022;105(2):368504221102786.","journal-title":"Sci Prog"},{"key":"3472_CR28","doi-asserted-by":"crossref","unstructured":"Sun L, Huang X, Wang J, Yuan C, Zhao H, Li D et al. Eltrombopag plus Diacerein vs. eltrombopag in patients with ITP: a multicenter, randomized, open-label, phase 2 trial. Blood. 2024.","DOI":"10.1182\/blood.2024025067"},{"issue":"6","key":"3472_CR29","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/bjh.19345","volume":"204","author":"N Cooper","year":"2024","unstructured":"Cooper N, Scully M, Percy C, Nicolson PLR, Lowe G, Bagot CN, et al. Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: results from the TRAIT study. Br J Haematol. 2024;204(6):2442\u201352.","journal-title":"Br J Haematol"},{"issue":"2","key":"3472_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/annrheumdis-2020-218419","volume":"80","author":"V Molander","year":"2021","unstructured":"Molander V, Bower H, Frisell T, Askling J. Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Ann Rheum Dis. 2021;80(2):169\u201375.","journal-title":"Ann Rheum Dis"},{"key":"3472_CR31","doi-asserted-by":"publisher","first-page":"100774","DOI":"10.1016\/j.blre.2020.100774","volume":"47","author":"WEM van Dijk","year":"2021","unstructured":"van Dijk WEM, Brandwijk ON, Heitink-Polle KMJ, Schutgens REG, van Galen KPM, Urbanus RT. Hemostatic changes by thrombopoietin-receptor agonists in immune thrombocytopenia patients. Blood Rev. 2021;47:100774.","journal-title":"Blood Rev"},{"issue":"6","key":"3472_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","volume":"16","author":"S Audia","year":"2017","unstructured":"Audia S, Mah\u00e9vas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16(6):620\u201332.","journal-title":"Autoimmun Rev"},{"issue":"50","key":"3472_CR33","doi-asserted-by":"publisher","first-page":"e5565","DOI":"10.1097\/MD.0000000000005565","volume":"95","author":"Y Liu","year":"2016","unstructured":"Liu Y, Chen S, Sun Y, Lin Q, Liao X, Zhang J, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: a retrospective study. Med (Baltim). 2016;95(50):e5565.","journal-title":"Med (Baltim)"},{"issue":"12","key":"3472_CR34","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s10067-013-2344-x","volume":"32","author":"H Chen","year":"2013","unstructured":"Chen H, Zhou S, Su D, Lu L, Li X, Sun L. High-dose methylprednisolone pulse therapy upregulated Fc\u03b3RIIb expression on B cells in primary Sj\u00f6gren\u2019s syndrome patients with thrombocytopenia. Clin Rheumatol. 2013;32(12):1783\u201390.","journal-title":"Clin Rheumatol"},{"key":"3472_CR35","doi-asserted-by":"publisher","first-page":"637659","DOI":"10.3389\/fimmu.2021.637659","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang S, Qu J, Wang L, Li M, Xu D, Zhao Y, et al. Activation of toll-like receptor 7 signaling pathway in primary Sj\u00f6gren\u2019s Syndrome-Associated Thrombocytopenia. Front Immunol. 2021;12:637659.","journal-title":"Front Immunol"},{"key":"3472_CR36","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.12659\/MSM.895144","volume":"21","author":"Y-H Hu","year":"2015","unstructured":"Hu Y-H, Zhou P-F, Long G-F, Tian X, Guo Y-F, Pang A-M, et al. Elevated plasma P-Selectin autoantibodies in primary Sj\u00f6gren Syndrome patients with Thrombocytopenia. Med Sci Monit. 2015;21:3690\u20135.","journal-title":"Med Sci Monit"},{"issue":"1","key":"3472_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10067-023-06818-y","volume":"43","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Bi H, Luo X, Pang A, Zhang P, Cui Y. Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sj\u00f6gren syndrome with thrombocytopenia. Clin Rheumatol. 2024;43(1):307\u201314.","journal-title":"Clin Rheumatol"},{"key":"3472_CR38","doi-asserted-by":"publisher","first-page":"102887","DOI":"10.1016\/j.jaut.2022.102887","volume":"132","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Cheng Y, Ma S, Li T, Chen Z, Zuo X, et al. Systemic lupus erythematosus-complicating immune thrombocytopenia: from pathogenesis to treatment. J Autoimmun. 2022;132:102887.","journal-title":"J Autoimmun"},{"issue":"13","key":"3472_CR39","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1177\/0961203310375268","volume":"19","author":"LD Zhao","year":"2010","unstructured":"Zhao LD, Li Y, Smith MF, Wang JS, Zhang W, Tang FL, et al. Expressions of BAFF\/BAFF receptors and their correlation with disease activity in Chinese SLE patients. Lupus. 2010;19(13):1534\u201349.","journal-title":"Lupus"},{"issue":"20","key":"3472_CR40","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1182\/bloodadvances.2020003860","volume":"5","author":"T-S Yu","year":"2021","unstructured":"Yu T-S, Wang H-Y, Zhao Y-J, Yu Y-F, Hou Y, Liu S, et al. Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood Adv. 2021;5(20):4087\u2013101.","journal-title":"Blood Adv"},{"issue":"12","key":"3472_CR41","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1177\/0961203310367583","volume":"24","author":"SH Park","year":"2015","unstructured":"Park SH, Kim JY, Kim SK, Choe JY, Kim SG, Ryoo HM. Regulatory T-cells in systemic lupus erythematosus-associated thrombocytopenia: a comparison with idiopathic thrombocytopenic purpura. Lupus. 2015;24(12):e4.","journal-title":"Lupus"},{"key":"3472_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.thromres.2022.02.021","volume":"213","author":"G Zhang","year":"2022","unstructured":"Zhang G, Yang P, Liu X, Liu H, Wang J, Wang J, et al. HMGB1 is increased in patients with immune thrombocytopenia and negatively associates with Tregs. Thromb Res. 2022;213:128\u201336.","journal-title":"Thromb Res"},{"issue":"5","key":"3472_CR43","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/bjh.16334","volume":"188","author":"JR Vrbensky","year":"2020","unstructured":"Vrbensky JR, Arnold DM, Kelton JG, Smith JW, Jaffer AM, Larch\u00e9 M, et al. Increased cytotoxic potential of CD8\u2009+\u2009T cells in immune thrombocytopenia. Br J Haematol. 2020;188(5):e72\u20136.","journal-title":"Br J Haematol"},{"key":"3472_CR44","doi-asserted-by":"publisher","first-page":"101141","DOI":"10.1016\/j.blre.2023.101141","volume":"63","author":"T Moulinet","year":"2024","unstructured":"Moulinet T, Moussu A, Pierson L, Pagliuca S. The many facets of immune-mediated thrombocytopenia: principles of immunobiology and immunotherapy. Blood Rev. 2024;63:101141.","journal-title":"Blood Rev"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03472-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T08:06:38Z","timestamp":1736496398000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03472-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3472"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03472-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the medical ethics research committee of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, with a waiver for informed consent. The trial registration number is NCT06458803.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement and trial registration number"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Patients and\/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}